Pharma

Poolbeg Pharma could reach €1bn valuation, says chief executive

Dublin-headquartered biopharma company is targeting the growing infectious disease market

Jeremy Skillington, chief executive of Poolbeg Pharma: ‘it’s a case of Amyrt 2.0, let’s do this again.’ Picture: Fergal Phillips